It is reported that the Chief Executive Officer of the National Medicines Regulatory Authority (NMRA) Dr. Vijith Gunasekara has been removed from that position.Sri Lanka Latest News
According to informed sources, he was removed on a collective decision taken by the board members of NMRA.
Accordingly, the Chief Executive Officer is to be absorbed into the Ministry of Health.
Dr. Gunasekara got into a lot of controversy for importing substandard human intravenous immunoglobulin (IVIG) using fake documents.
Thus, Dr. Gunasekara, Director of Supply Division of the Ministry of Health Dr. Kapila Wickramanayake and the owner of the company who prepared false documents to import substandard human intravenous immunoglobulin (IVIG) were banned from traveling abroad.
Meanwhile, Dr. Vijith Gunasekara was recently accused of destroying some essential documents of NMRA, according to the Government Pharmacists Association.
As previously reported, the CEO had been informed to resign.
However, he has refused to do so.
The National Drug Regulatory Authority, headed by Dr. Vijith Gunasekara, former Chairman and Chief Executive Officer of NMRA, faced many allegations regarding the influx of substandard drugs into the country in the past.
